Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure

Author:

Elzeneini Mohammed,Aranda Juan M.,Al-Ani Mohammad,Ahmed Mustafa M.,Parker Alex M.,Vilaro Juan R.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Metra M, Ponikowski P, Dickstein K, McMurray JJV, Gavazzi A, Bergh C-H et al (2007) Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 9:684–694. https://doi.org/10.1016/j.ejheart.2007.04.003

2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the Aamerican College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119. https://doi.org/10.1161/CIRCULATIONAHA.109.192065

3. Yancy CW, Jessup M, Chair V, Bozkurt B, Butler J, Casey DE et al (2013) 2013 ACCF/AHA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAC 62:1495–1539. https://doi.org/10.1016/j.jacc.2013.05.020

4. Aranda JM, Schofield RS, Pauly DF, Cleeton TS, Walker TC, Monroe VS et al (2003) Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J 145:324–329. https://doi.org/10.1067/mhj.2003.50

5. Brozena SC, Twomey C, Goldberg LR, Desai SS, Drachman B, Kao A et al (2004) A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home. J Heart Lung Transplant 23:1082–1086. https://doi.org/10.1016/j.healun.2003.08.017

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3